Photoaging Clinical Trial
Official title:
Prospective, Randomized Controlled Study on the Effects of Dietary Soy Protein on Facial
NCT number | NCT04871750 |
Other study ID # | SYW_01 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 15, 2021 |
Est. completion date | June 2023 |
Soy and soy-derived products are the primary dietary sources of isoflavones, particularly daidzein and genistein, for humans. Isoflavones are noted to have several effects on the skin including proliferation of keratinocytes resulting in epidermal thickening and increasing collagen and moisture content of the skin. Previous work has shown that the ingestion of an oral supplement containing soy isoflavones as a component led to a clinically measurable improvement in wrinkle depth after 14 weeks of supplementation. Ingestion of soy-based products has been shown to shift the Bifidobacteria and Lactobacilli among the gut microbiota and modulate the ratio of Firmicutes to Bacteroidetes. Many studies have shown that short-chain fatty acids result from beneficial shifts in the gut microbiome and may influence the inflammatory state of the skin. Therefore, the study aims to investigate whether soy-derived isoflavone can reduce wrinkles and alter both gut microbiome and short-chain fatty acids.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | June 2023 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 50 Years to 70 Years |
Eligibility | Inclusion Criteria: - Postmenopausal females, 50 to 70 years of age - Fitzpatrick skin type I or II, based on skin melanin content - BMI 18.5-35 kg/m2 - Must be willing to comply with all protocol requirements - Must be willing to have flash photo facial images taken with the imaging systems Exclusion Criteria: - Any systemic or antibiotics (injected or oral) within 6 months of starting study - Any topical antibiotic or benzoyl peroxide within 1 month of starting study or any subject unwilling to refrain from washout of topical antibacterial or benzoyl peroxide ingredient. - Allergic to soy and milk products - Fruit consumption > 2 cups/day - Vegetable consumption > 3 cups/day for females - Fruit juice consumption > 1 cup/day - Coffee consumption > 1 cup per day - Alcohol consumption = 3 servings per week (1 serving = 1 bottle of beer, ½ glass of wine, or 1 shot of hard liquor) - Self-reported malabsorption - Any oral probiotic or prebiotic supplementation within past 1 month at the discretion of the investigator. Probiotic and prebiotic containing foods are NOT considered an exclusion. - Subjects must have no history of malignancy or cancer or diagnosis of gastrointestinal inflammatory diseases, no history or diagnosis of epilepsy, no history or diagnosis of immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis) - Has a condition or is on medication the investigator and/or designee believe could jeopardize the safety of the subject, interfere with the evaluation, or confound the interpretation of the study results - Is participating in a concurrent intervention based clinical research study - Commencement of a new diet (such as the ketogenic diet) or supplements within the 1 month prior to initiating participation, at the discretion of the investigator. - Use of medications that alter blood lipids, such as statins and anti-hyperlipidemic medications - Is participating in or has participated in a intervention based facial study at this or any other facility in the past 2 weeks. Participation in survey-based studies are approved at the discretion of the investigator. - Has a skin disease on face that will interfere with image collection and assessment in the opinion of the investigator - Persons unwilling to avoid the following during the 4 weeks prior and during the duration of the study: self-tanning, spa tanning, sun tanning, or artificial tanning. - Planned vacation to sunny destination with the intention of sun tanning during the duration of the study. - Persons who regularly undergo sauna treatments (dry or wet) or who swim daily. Known allergy or irritation to the supplement or facial products utilized in the study - Current tobacco smokers, OR those that have smoked tobacco over the past year, OR a 5 year-pack year history of smoking tobacco - Prisoners - Adults unable to consent - Vegans and vegetarians |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Integrative Skin Science and Research | United Soybean Board |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Facial wrinkles | Wrinkle severity score measured by Facial Image Analysis System | week 24 | |
Secondary | Procollagen I expression | Assess with biopsy (optional participation) | 24 | |
Secondary | Pigment intensity score | Measured by the 3D Clarity Pro® Facial Modeling and Analysis System (Brigh-Tex BioPhotonics, San Jose, CA) | week 24 | |
Secondary | Blood levels of soy isoflavones and metabolites | Blood samples will be collected | week 24 | |
Secondary | Gut microbiome | Evaluate changes in the gut microbiome (Bifidobacteria and Lactobacilli, ratio of Firmicutes to Bacteroidetes) through stool samples | week 24 | |
Secondary | Blood lipidome | Assess changes in butyrate, propionate, and acetate levels | week 24 | |
Secondary | Facial wrinkles | Wrinkle score measured by Facial Image Analysis System | week 8 | |
Secondary | Facial wrinkles | Wrinkle score measured by Facial Image Analysis System | week 16 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05271136 -
A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum
|
N/A | |
Completed |
NCT05514782 -
A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum
|
N/A | |
Completed |
NCT04911374 -
An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream
|
N/A | |
Completed |
NCT04586816 -
Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging
|
N/A | |
Completed |
NCT05039723 -
Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
|
Phase 4 | |
Not yet recruiting |
NCT05004909 -
Effectivity of 1 Finger Tip Unit Compared to 2 Finger Tip Units 0.05% Tretinoin Cream
|
N/A | |
Completed |
NCT06366503 -
Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation
|
N/A | |
Completed |
NCT05027282 -
Safety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength Treatment
|
N/A | |
Not yet recruiting |
NCT06096649 -
The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin
|
N/A | |
Completed |
NCT03661697 -
Combination Versus Laser Treatment Only
|
N/A | |
Completed |
NCT03948945 -
Efficacy and Safety of Profile HaloTM Mixed Fractional Laser on Treating of Facial and Neck Photoaging.
|
N/A | |
Completed |
NCT06148558 -
A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+
|
N/A | |
Enrolling by invitation |
NCT06188338 -
A 56-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Recruiting |
NCT06195605 -
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
|
N/A | |
Not yet recruiting |
NCT04869852 -
Effects of Mango Intake on Skin Health and Gut Microbiome Changes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT02126644 -
The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Photoaging
|
Phase 2 | |
Active, not recruiting |
NCT01372566 -
Effect of Platelet Rich Plasma on Photoaged Skin
|
Phase 1/Phase 2 | |
Unknown status |
NCT00842907 -
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
|
Phase 2 | |
Completed |
NCT03112863 -
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
|
Early Phase 1 | |
Recruiting |
NCT05386368 -
RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients
|
Phase 4 |